Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Spruce Biosciences Inc (NQ: SPRB ) 0.4574 -0.0208 (-4.35%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Spruce Biosciences Inc < Previous 1 2 3 Next > Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates August 12, 2024 From Spruce Biosciences, Inc. Via Business Wire Major Potential: 5 NASDAQ / NYSE Stocks Under $1 SGMO, FTCI, VTAK, SPRB, DNA July 11, 2024 Via AB Newswire Spruce Biosciences Recognized as a Bay Area Best Place to Work June 06, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD) June 04, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024 June 03, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference May 23, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society May 22, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Inc. (NASDAQ: SPRB) Making Surprising Moves in Tuesday Session September 12, 2023 Via Investor Brand Network Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates May 13, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences to Participate in May Investor Conferences May 01, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting April 30, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting April 22, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings March 21, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings March 14, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates March 13, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH March 13, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference January 30, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia January 22, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH January 05, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024 January 04, 2024 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates November 13, 2023 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences to Participate in the Jefferies London Healthcare Conference November 02, 2023 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal Hyperplasia October 18, 2023 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference August 28, 2023 From Spruce Biosciences Via Business Wire Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates August 14, 2023 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Announces Acceptance of Abstract for Presentation at the Annual Meeting of the Endocrine Society (ENDO 2023) June 12, 2023 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Appoints Percival Barretto-Ko to Board of Directors May 25, 2023 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences to Participate in the Jefferies Healthcare Conference May 24, 2023 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES Gala May 22, 2023 From Spruce Biosciences, Inc. Via Business Wire Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates May 15, 2023 From Spruce Biosciences, Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.